1 / 15

Section 1: CKD Epidemiology

Explore the global epidemic of Chronic Kidney Disease, latest data, and interventions for delaying disease progression. Learn about under-recognition, late referrals, and opportunities for improved patient outcomes.

martinmitchell
Download Presentation

Section 1: CKD Epidemiology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Section 1: CKD Epidemiology

  2. The Problem • Chronic Kidney Disease is an epidemic worldwide • Growth 6-8% per annum of dialysis patients • Accumulating data re: possibility of delaying the progression of kidney disease, using multiple drug and behaviour intervention therapies. • Under-recognition at earlier stages of kidney dysfunction persists • Late referral • Lost opportunities for improved patient outcomes

  3. RRT Modalities 36,542 DOD/0503-04

  4. 300 250 0 - 44 45 - 64 200 65+ Age Specific Rate per Million Diabetics 150 Total 100 50 0 93 85 86 87 88 90 91 92 94 95 99 96 80 81 82 83 84 97 98 2000 2001 Year Patients Accepted in the UK for Renal Replacement Therapy

  5. Cadaveric Kidney Donors & Transplants and End of Year Kidney Waiting List, UK, 1994-2003 DOD/0503-04

  6. Prevalence of renal replacement therapy

  7. Estimates of Prevalence of CKD in the US: NHANES III Adapted from Am J Kidney Dis 2002; 39 (2, Suppl. 1): S17-S31

  8. NICE: 2008 Classification of CKDwaking up to the impact of proteinuria • Stage 1: GFR>90 + abnormal urinalysis • Stage 2: GFR 60-89 + abnormal urinalysis • Stage 3A: GFR 45-59 • Stage 3B: GFR 30-44 • Stage 4: GFR 15-29 • Stage 5: GFR <15 or dialysis dependent Suffix P denotes presence of proteinuria (ACR>30 or PCR>50)

  9. National Disease Prevalence Survey (%)

  10. CKD: A Typical GP Practice of 10000 5 6 15 4 60 Stage of Kidney Disease 30 (GFR) 380 3 60 2 460 90 1

  11. Incident Rates by Primary Diagnosis (per million population, unadjusted) USRDS, 2000

  12. Obesity Trends: UK

  13. Life expectancy: UK

More Related